The markets saw a slight recovery on Tuesday after a four-day losing streak. Several companies are in focus due to recent news and quarterl...

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last week's approval for...

Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 mg & 100 mg) fo...

Zydus Lifesciences share price: Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multi...

LIC Housing Finance said its board has given a nod to borrow Rs 1.23 lakh crore through loans, issue of bonds, and other instruments, in th...

IT services company Wipro reported 24% growth in its consolidated net profit at Rs 3,354 crore, while revenue from operations rose by a mar...

Global brokerage firm Jefferies has upgraded Zydus Lifesciences to a 'Buy' rating, citing the strength of the company’s US pipeline as a ma...

JSW Energy's board to meet on April 2 to consider a proposal for raising of funds through the issuance of eligible securities of the compan...

Shares of Tata Chemicals and Canara Bank will be in focus today as the companies will go ex-dividend today. Tata Chemicals has also followe...

USFDA has conducted an inspection at Zydus’ animal health drug manufacturing facility at SEZ, Ahmedabad. The inspection concluded with nil ...

The approval granted by the US Food and Drug Administration (USFDA) is to market Triazolam tablets of strengths 0.125 mg and 0.25 mg, the c...

Under the terms of the agreement, Sentynl will acquire global rights to Nulibry and will be responsible for the ongoing development and com...

Drug maker Cadila Healthcare (Zydus Cadila), on Thursday said its antimalarial drug ZY19489 (MMV253), currently in development together wit...

Orphan Drug status in Europe is given to medicines with the potential to be safe and effective treatments for rare, life-threatening, or ch...

Zydus Cadila, which is a part of Cadila Group, said orphan drug designation provides eligibility for certain development incentives, includ...

Zydus is the fifth company to launch a copy of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Li...

Amit Rajan, Director, Celogen Life says that Micro Labs will quickly come out of the FDA and midcap space as they have a good R&D pipeline.